1508250-72-3 67HTX614WR Nazartinib mesylate UNII-67HTX614WR 4-Pyridinecarboxamide, N-(7-chloro-1-((3R)-1-((2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl)hexahydro-1H-azepin-3-yl)-1H-benzimidazol-2-yl)-2-methyl-, methanesulfonate (1:1) EGF-816 mesylate CAS 1508250-72-3

Purity 97%+In StockPharmaceutical Standards
CAS No.1508250-72-3
Molecular FormulaC26H31ClN6O2 CH4O3S
Molecular WeightN/A
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

1508250-72-3 67HTX614WR Nazartinib mesylate UNII-67HTX614WR 4-Pyridinecarboxamide, N-(7-chloro-1-((3R)-1-((2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl)hexahydro-1H-azepin-3-yl)-1H-benzimidazol-2-yl)-2-methyl-, methanesulfonate (1:1) EGF-816 mesylate CAS 1508250-72-3 chemical structure

Description

1508250-72-3 67HTX614WR Nazartinib mesylate UNII-67HTX614WR 4-Pyridinecarboxamide, N-(7-chloro-1-((3R)-1-((2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl)hexahydro-1H-azepin-3-yl)-1H-benzimidazol-2-yl)-2-methyl-, methanesulfonate (1:1) EGF-816 mesylate (CAS 1508250-72-3) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C26H31ClN6O2 CH4O3S. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.

Physical & Chemical Properties

Molecular FormulaC26H31ClN6O2 CH4O3S
Molecular Weight591.12 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)13.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1992
Halogen ContentCl-containing
Nitrogen Atoms6
Sulfur Atoms1

Recommended Standards

Why CATO?